Hemab Therapeutics Holdings (COAG) Stock Price & Financial Analysis
Hemab Therapeutics Holdings Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Hemab Therapeutics Holdings
What is the current stock price for COAG?
As of the latest trading session, COAG stock trades at $44.41. The 52-week range is $23.00–$55.42, with a day range of $43.29–$45.49.
What is the P/E ratio for COAG?
The P/E ratio (Price-to-Earnings) for COAG is shown in the Key Statistics section. This valuation metric helps compare Hemab Therapeutics Holdings, Inc. to industry peers.
Does COAG pay dividends?
Hemab Therapeutics Holdings does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for COAG?
Based on 4 analysts, the consensus for COAG is Buy.
What is the market cap of COAG?
Hemab Therapeutics Holdings's market capitalization is $1.96B, classifying it as a small-cap company. Hemab Therapeutics Holdings operates in the Healthcare sector within the Biotechnology industry.